SPOTLIGHT -
Apothecary Offers Historical Internship for Pharmacy Students
See how some students have opted for a unique conclusion to their studies.
Grifols Launches Xembify, A New Primary Immunodeficiency Treatment
20% subcutaneous immunoglobulin therapy.
ISMP Unveils 2020-2021 Best Safety Practice Updates at ASHP Midyear
Two new best practices, a new classification, and 5 updated existing rules.
Lack of Quality Evidence Around Cannabis Use Complicates Patient Management in the Health-System Setting
Takeaways from a roundtable at ASHP 2019.
ASHP Announces 2019 Best Practice Award Winners
Presented at the ASHP Midyear 2019.
Interdisciplinary Teams Combined with CGM a Winning Combination for Patients with Diabetes
Based upon results from a military population study presented at ASHP 2019.
ASHP Honors Two of their Own at Midyear Opening Ceremony
The pair were recognized for contributions to the association and industry.
Pharmacists in a Good Position to Counsel About Humulin R U-500 Use
Results at ASHP 2019 suggest potential for administration errors without proper guidance.
FDA Approves Amgen’s Infliximab-axxq
Biosimilar to Remicade
Ubrogepant Shows Effective Elimination of Migraine Pain and Symptoms
Allergan’s positive phase 3 trial results indicate a potential use for the CGRP receptor agonist.
Atezolizumab Approved for New Combination Cancer Treatment
Monoclonal antibody originally approved in 2016.
FDA Approves Acalabrutinib for CLL, SLL
Recent approval under new international Project Orbis.
Givosiran Approved for Acute Hepatic Porphyria
Ultra-rare, potentially life-threatening genetic disease.
Voxelotor Tablets for Sickle Cell Disease Granted Accelerated Approval by FDA
Hemoglobin S Polymerization inhibitor oral treatment.
FDA Approves Cenobamate for Partial-Onset Seizures
Approved for patients 18 years of age and older
FDA Approves Cefiderocol for cUTIs in Adults
Antibiotic with a novel penetrative mechanism.
Pfizer Gains FDA Approval for Humira Biosimilar
Expected U.S. launch in 2023.
Crizanlizumab for Sickle Cell Pain Reduction Approved by FDA
First and currently only biological targeting P-selectin.
FDA Approves Zanubrutinib for Mantle Cell Lymphoma
MCL is an aggressive form of NHL
FDA Approves Luspaterecpt-aamt for Anemia
Shown to reduce regular RBC transfusions in adults with beta thalassemia.
New Filgrastim Biosimilar Approved by FDA
Fourth filgrastim biosimilar from Sandoz, expected ASAP.
FDA Warns of Biotin Interference in Lab Assays
Could lead to falsely high or low results, especially troponin assays.
Quadrivalent Flu Vaccine Approved for Elders
Approved for ages 65 and older.
FDA Approves Talicia for Helicobacter pylori Infections
First and currently only rifabutin-based H. pylori therapy approved.
New Multiple Sclerosis Treatment Approved by FDA
Delayed-release oral capsules for various forms of the disease.
Baxdela Now Approved for Bacterial Pneumonia
Commercial launch suspended due to manufacturer liquidity.
FDA Approves Biophen for Hypotension in Anesthesia Settings
New formulation improves safety for patients.
FDA Approves Mealtime Insulin for Use with Infusion Pumps
Previously approved for IV infusion.
Ustekinumab Gains FDA Approval as Ulcerative Colitis Treatment
Fourth indication expansion for the 2009 drug.
Dapagliflozin Approved to Reduce Hospitalization in Diabetes Patients
Reduces risk for heart failure and cardiovascular disease hospitalizations.
